High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin.
1996 ◽
Vol 93
(6)
◽
pp. 2464-2469
◽
2014 ◽
Vol 12
(32)
◽
pp. 6094-6104
◽
2010 ◽
Vol 20
(19)
◽
pp. 5839-5842
◽
2013 ◽
Vol 64
◽
pp. 579-588
◽
2014 ◽
Vol 83
◽
pp. 256-273
◽
2015 ◽
Vol 90
◽
pp. 68-81
◽
2010 ◽
Vol 4
(1)
◽
2003 ◽
Vol 669
(1-2)
◽
pp. 109-123
◽